Li Wu’s group observed SAMHD1 promotor methylation [226] in an aggressive subtype of CTCL patient samples, indicating transcriptional repression as a SAMHD1 regulation mechanism in CTCL. The gene discussed is SAMHD1; the disease is primary cutaneous T-cell non-Hodgkin lymphoma.